Company in Late-Stage Negotiations to Secure Distribution Agreement for Additional COVID-19 IgG/IgM Rapid Test Which is Approved by China's National Medical Products Administration (NMPA) ENGLEWOOD, ...

The analysis included results from 2 tests that have received EUA: the SARS-CoV-2 ELISA test (Euroimmun) and the COVID-19 IgG/IgM Rapid Test Cassette (Healgen). The Food and Drug Administration (FDA) ...

Announcing a new article publication for Zoonoses journal. The COVID-19 pandemic, which was caused by SARS-CoV-2, has had a significant effect on global public health, economies, and societies ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Nirmidas Biotech, Inc., a member of the StartX Med COVID-19 Task Force, announces its second FDA Emergency Use Authorization (EUA) for their COVID-19 rapid antibody ...

Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 in Wuhan, China, and rapidly progressed into a devastating pandemic affecting ...

The blood test detects a type of antibody, called IgM, that’s present after a person has been recently infected with COVID-19, Abbott said in a news release. It’s the second antibody test made by ...

As states and countries begin rolling back their lockdown restrictions, the results of widespread antibody testing may guide policies on whether schools can reopen or employees can return to work. But ...